Citations

Clear

3485 citation(s) found for "Sy, Sarah".

Creatinine to Cystatin-C Ratio in Renal Cell Carcinoma: A Clinically Pragmatic Prognostic Factor and Sarcopenia Biomarker
Schmeusser, Benjamin N. , Biermann, Henry, Ali, Adil , Midenberg, Eric, Helman, Talia , Armas‐Phan, Manuel , Nabavizadeh, Reza , Joshi, Shreyas , Bilen, Mehmet Asım , Ogan, Kenneth , Master, Viraj A. , Joshi, Shreyas S, Narayan, Vikram M. , Psutka, Sarah P , Nicaise, Edouard , Patil, Dattatraya , Psutka, Sarah P.

Mayo Clinic

The Oncologist | August 4, 2023 | Volume: 28 | Issue: 12 | Pages: e1219-e1229

10.1093/oncolo/oyad218 | PMID 37540787 Get It

Abstract Introduction Low creatinine to cystatin-C ratio (Cr/Cys-C) may be a biomarker for low-muscle mass. Furthermore, low Cr/Cys-C is associated with decreased overall survival (OS), but to date, has not been examined in patients with renal cell carcinoma (RCC). Our objective is to evaluate associations between low Cr/Cys-C ratio and OS and recurrence-free survival (RFS) in patients with RCC treated with nephrectomy. Methods We performed a retrospective review of patients with RCC treated with nephrectomy. Patients with end-stage renal disease and less than 1-year follow up were excluded. Cr/Cys-C was dichotomized at the median for the cohort (low vs. high). OS and RFS for patients with high versus low Cr/Cys-C were estimated with the Kaplan-Meier method, and associations with the outcomes of interest were modeled using Cox proportional Hazards models. Associations between Cr/Cys-C and skeletal muscle mass were assessed with correlations and logistic regression. Results A total of 255 patients were analyzed, with a median age of 64. Median (IQR) Cr/Cys-C was 1 (0.8-1.2). Low Cr/Cys-C was associated with age, female sex, Eastern Cooperative Oncology Group Performance Status ≥1, TNM stage, and tumor size. Kaplan-Meier and Cox regression analysis demonstrated an association between low Cr/Cys-C and decreased OS (HR = 2.97, 95%CI, 1.12-7.90, P =0.029) and RFS (HR = 3.31, 95%CI, 1.26-8.66, P = .015). Furthermore, a low Cr/Cys-C indicated a 2-3 increase in risk of radiographic sarcopenia. Conclusions Lower Cr/Cys-C is associated with inferior oncologic outcomes in RCC and, pending validation, may have utility as a serum biomarker for the presence of sarcopenia in patients with RCC treated with nephrectomy.
Multicenter Survival Analysis and Application of an Olfactory Neuroblastoma Staging Modification Incorporating Hyams Grade
Champagne, Pierre‐Olivier , Chan, Erik, Ciporen, Jeremy , Chaskes, Mark B., Fernandez‐Miranda, Juan C. , Gardner, Paul A. , Hwang, Peter H. , Ji, Keven Seung Yong , Kalyvas, Aristotelis , Kong, Keonho A., McMillan, Ryan A. , O’Byrne, Jamie, Patel, Chirag , Patel, Zara M. , Celda, María Peris, Sanusi, Olabisi , Thorp, Brian D. , Young, Sarah C. , Zenonos, Georgios A. , Zwagerman, Nathan T. , McMillan, Ryan, O'Byrne, Jamie, Peris Celda, Maria, Pinheiro-Neto, Carlos, Patel, Zara , Hwang, Peter H , Choby, Garret , Geltzeiler, Mathew , Almeida, João Paulo , Nayak, Jayakar V. , Pinheiro‐Neto, Carlos , Snyderman, Carl H , Gompel, Jamie J. Van , Wang, Eric W

Mayo Clinic

JAMA Otolaryngology–Head & Neck Surgery | August 3, 2023 | Volume: 149 | Issue: 9 | Pages: 837

10.1001/jamaoto.2023.1939 | PMID 37535372 Get It

ImportanceCurrent olfactory neuroblastoma (ONB) staging systems inadequately delineate locally advanced tumors, do not incorporate tumor grade, and poorly estimate survival and recurrence.ObjectiveThe primary aims of this study were to (1) examine the clinical covariates associated with survival and recurrence of ONB in a modern-era multicenter cohort and (2) incorporate Hyams tumor grade into existing staging systems to assess its ability to estimate survival and recurrence.Design, Setting, and ParticipantsThis retrospective, multicenter, case-control study included patients with ONB who underwent treatment between January 1, 2005, and December 31, 2021, at 9 North American academic medical centers.InterventionStandard-of-care ONB treatment.Main Outcome and MeasuresThe main outcomes were overall survival (OS), disease-free survival (DFS), and disease-specific survival (DSS) as C statistics for model prediction.ResultsA total of 256 patients with ONB (mean [SD] age, 52.0 [15.6] years; 115 female [44.9%]; 141 male [55.1%]) were included. The 5-year rate for OS was 83.5% (95% CI, 78.3%-89.1%); for DFS, 70.8% (95% CI, 64.3%-78.0%); and for DSS, 94.1% (95% CI, 90.5%-97.8%). On multivariable analysis, age, American Joint Committee on Cancer (AJCC) stage, involvement of bilateral maxillary sinuses, and positive margins were associated with OS. Only AJCC stage was associated with DFS. Only N stage was associated with DSS. When assessing the ability of staging systems to estimate OS, the best-performing model was the novel modification of the Dulguerov system (C statistic, 0.66; 95% CI, 0.59-0.76), and the Kadish system performed most poorly (C statistic, 0.57; 95% CI, 0.50-0.63). Regarding estimation of DFS, the modified Kadish system performed most poorly (C statistic, 0.55; 95% CI, 0.51-0.66), while the novel modification of the AJCC system performed the best (C statistic, 0.70; 95% CI, 0.66-0.80). Regarding estimation of DSS, the modified Kadish system was the best-performing model (C statistic, 0.79; 95% CI, 0.70-0.94), and the unmodified Kadish performed the worst (C statistic, 0.56; 95% CI, 0.51-0.68). The ability for novel ONB staging systems to estimate disease progression across stages was also assessed. In the novel Kadish staging system, patients with stage VI disease were approximately 7 times as likely to experience disease progression as patients with stage I disease (hazard ratio [HR], 6.84; 95% CI, 1.60-29.20). Results were similar for the novel modified Kadish system (HR, 8.99; 95% CI, 1.62-49.85) and the novel Dulguerov system (HR, 6.86; 95% CI, 2.74-17.18).Conclusions and RelevanceThe study findings indicate that 5-year OS for ONB is favorable and that incorporation of Hyams grade into traditional ONB staging systems is associated with improved estimation of disease progression.
Evaluation of safety and care outcomes after the introduction of a virtual registered nurse model
Savitz, Samuel T. , Frederick, Ryannon K., Sangaralingham, Lindsey R. , Anderson, Stephanie S., Bell, Sarah J. , Lampman, Michelle A. , Habermann, Elizabeth B.

Mayo Clinic

Health Services Research | August 1, 2023 | Volume: 58 | Issue: 5 | Pages: 999-1013

10.1111/1475-6773.14208 | PMID 37525521 Get It

AbstractObjectiveTo evaluate the impact of a virtual registered nurse (ViRN) model on safety and care outcomes. ViRN is a telemedicine intervention that enables an experienced virtual nurse to assist the in‐person care team in providing care to patients.Data Sources and Study SettingElectronic health records data were utilized from the Mayo Clinic during the intervention (December 2020–November 2021) and historical periods (December 2018–November 2019). ViRN was implemented on general medical units at the Mayo Clinic Rochester. We used general medical units at the Mayo Clinic Arizona as the comparison group.Study DesignThis study used a difference‐in‐differences design to evaluate the impact of ViRN compared to usual care on transfer to the intensive care unit (ICU), inpatient mortality, and length of stay (LOS). We used logistic regression for transfer to the ICU and inpatient mortality and negative binomial regression for LOS. We controlled for demographics, patient interaction with the health system, clinical characteristics, and admission characteristics. We clustered standard errors to account for patients who have multiple admissions during the study period.Principal FindingsThere were no significant differences for transfer to the ICU (average marginal effect (AME) −0.08 percentage point [95% confidence interval (CI): −1.34, 1.18]), inpatient mortality (AME 0.43 percentage point [95% CI: −0.33, 1.18]), or LOS (AME −0.20 days [95% CI: −0.57, 0.17]). The findings were mostly consistent across the sensitivity analyses.ConclusionsOur results suggest that ViRN led to similar outcomes as usual care in general medical units. These findings support the potential to develop more advanced models of ViRN at the Mayo Clinic and the dissemination of the ViRN model to other systems. In the context of staffing shortages and other disruptions to the delivery of nursing care, it is critical to understand whether new models like ViRN provide nurse staffing alternatives without negatively affecting outcomes.
Oral Glucose Tolerance Testing Using Candy: A Sweet Solution to Improve Screening in Children with Cystic Fibrosis?
Weeks, C. R. , Demirel, Nadir , Olson, Janelle A., Dean, Vicki, Pyrz, Caitlin, Creo, Ana L. , Weeks, Caroline , Jackson, Sarah, Olson, Janelle, Creo, Ana , Jackson, Sarah Elizabeth , Demirel, Nadir

Mayo Clinic

Children | July 31, 2023 | Volume: 10 | Issue: 8 | Pages: 1317

10.3390/children10081317 | PMID 37628316 Get It

Introduction: Oral glucose tolerance testing is recommended for all children with CF older than 9 years, yet compliance remains poor across centers. Methods: We performed a small pilot study assessing the glycemic curves and participant satisfaction in seven children and adolescents. Results: We chose a dextrose-based candy (Nerds®) free of any fat, fiber, gelatin, or corn syrup and performed the candy OGTT 1–4 days following the standard oral dextrose solution OGTT. Glucose values at 120 min were similar between the candy and oral dextrose solution (p = 0.8986). Conclusions: Our small pilot suggests that a carefully selected candy alternative may result in similar glycemic OGTT when compared to the standard oral dextrose solution. However, some participants preferred the oral dextrose solution to candy due to having to consume a large volume in a short period of time. This may have significant implications as centers consider candy alternatives to increase OGTT adherence rates.
O-065 Multicenter investigation into presentation, management and outcome of infectious intracranial aneurysms
Saad, Hassan , Newman, Sarah, Grossberg, Jonathan A , Cawley, C. Michael , Fox, C, Perez-Vaga, C, Burkhardt, Jan‐Karl , Salem, Mohamed M , Jabbour, Pascal , Starke, R, Lu, Victor M. , Levitt, M, Spiotta, Alejandro M , Alawieh, Ali , Dimisko, Laurie , Zohdy, Youssef M. , Pradilla, Gustavo , Jabbour, Pascal , Naamani, Kareem El , Schmidt, Richard F. , Gooch, Michael Reid , Abdelsalam, Ahmed , Levitt, M, Hertzberg, Vicki , Barrow, Daniel L. , Howard, Brian M

Mayo Clinic

SNIS 20th annual meeting oral abstracts | July 30, 2023 | Volume: No volume available | Issue: No issue available | Pages: A51.1-A51

10.1136/jnis-2023-snis.65 Get It

Later onset focal epilepsy with roots in childhood: Evidence from early learning difficulty and brain volumes in the Human Epilepsy Project
Pellinen, Jacob , Pardoe, Heath , Barnard, Sarah , French, Jacqueline A. , Knowlton, Robert C. , Lowenstein, Daniel H. , Cascino, Gregory D. , Glynn, Simon, Szaflarski, Jerzy P. , Morrison, Chris , Meador, Kimford J. , Investigators, the Human Epilepsy Project, O’Brien, Terence J. , Berkovic, Samuel F. , Cook, Mark , Altalib, Hamada , Barnard, Sarah , French, Jacqueline , Meador, Kimford J , Cook, Mark J , Pardoe, Heath R , Pellinen, Jacob , Sillau, Stefan , Jackson, Graeme D. , Kuzniecky, Ruben , Investigators, the Human Epilepsy Project

Mayo Clinic

Epilepsia | July 30, 2023 | Volume: 64 | Issue: 10 | Pages: 2761-2770

10.1111/epi.17727 | PMID 37517050 Get It

AbstractObjectiveVisual assessment of magnetic resonance imaging (MRI) from the Human Epilepsy Project 1 (HEP1) found 18% of participants had atrophic brain changes relative to age without known etiology. Here, we identify the underlying factors related to brain volume differences in people with focal epilepsy enrolled in HEP1.MethodsEnrollment data for participants with complete records and brain MRIs were analyzed, including 391 participants aged 12–60 years. HEP1 excluded developmental or cognitive delay with intelligence quotient <70, and participants reported any formal learning disability diagnoses, repeated grades, and remediation. Prediagnostic seizures were quantified by semiology, frequency, and duration. T1‐weighted brain MRIs were analyzed using Sequence Adaptive Multimodal Segmentation (FreeSurfer v7.2), from which a brain tissue volume to intracranial volume ratio was derived and compared to clinically relevant participant characteristics.ResultsBrain tissue volume changes observable on visual analyses were quantified, and a brain tissue volume to intracranial volume ratio was derived to compare with clinically relevant variables. Learning difficulties were associated with decreased brain tissue volume to intracranial volume, with a ratio reduction of .005 for each learning difficulty reported (95% confidence interval [CI] = −.007 to −.002, p = .0003). Each 10‐year increase in age at MRI was associated with a ratio reduction of .006 (95% CI = −.007 to −.005, p < .0001). For male participants, the ratio was .011 less than for female participants (95% CI = −.014 to −.007, p < .0001). There were no effects from seizures, employment, education, seizure semiology, or temporal lobe electroencephalographic abnormalities.SignificanceThis study shows lower brain tissue volume to intracranial volume in people with newly treated focal epilepsy and learning difficulties, suggesting developmental factors are an important marker of brain pathology related to neuroanatomical changes in focal epilepsy. Like the general population, there were also independent associations between brain volume, age, and sex in the study population.
Mental health in undergraduate engineering students: Identifying facilitators and barriers to seeking help
Wilson, Sarah , Hammer, Joseph H. , Hargis, Lucy, Miller, Melanie , Usher, Ellen L. , Usher, Ellen L , Wright, Courtney J.

Mayo Clinic

Journal of Engineering Education | July 28, 2023 | Volume: 112 | Issue: 4 | Pages: 963-986

10.1002/jee.20551 Get It

Abstract Background Engineering students encounter high levels of stress, which may negatively impact their mental health. Nevertheless, engineering students who experience mental health distress are less likely than their peers to seek professional help, even when controlling for gender and race/ethnicity. Purpose We examined beliefs that undergraduate engineering students have about barriers and facilitators to seeking professional help for their mental health. We also sought to identify cultural and systemic factors within and beyond engineering that might affect help‐seeking. Together, these beliefs influence students' sense of personal agency around seeking mental health care. Method We implemented a pragmatic qualitative design that incorporated the integrated behavioral model to investigate engineering students' ( N = 33) professional mental health help‐seeking beliefs. We used thematic analysis to analyze help‐seeking beliefs and perceived barriers and facilitators that students described during interviews. Results We identified four themes: Navigating the system impacts personal agency; sacrifices associated with help‐seeking act as a barrier; engineering culture acts as a barrier to help‐seeking; and student confidence in help‐seeking varies significantly. These themes portray the effect of perceived barriers and facilitators on students' personal agency for accessing mental health care. Our findings have implications for engineering departments and university counseling centers that want to minimize barriers to help‐seeking. Conclusions Engineering stakeholders must improve access to professional help for engineering students. Implementing changes to normalize help‐seeking behaviors, enhance personal agency, and facilitate engagement with mental health resources will create better conditions for engineers. Further research is necessary to understand how other beliefs (e.g., attitudes, perceived norms) inform the relationships between student mental health, professional help seeking, and engineering culture.
Mechanical Ventilation Training Curriculum for Pulmonary Critical Care Fellows during the COVID-19 Pandemic
Shiari, Aryan , Venkat, Divya , Mohamed, Abdelaziz , Lee, Sarah J., Sankari, Abdulghani , Shiari, Aryan

Mayo Clinic

ATS Scholar | July 27, 2023 | Volume: 4 | Issue: 3 | Pages: 362-371

10.34197/ats-scholar.2022-0048in | PMID 37795120 Get It

Abstract Background Mechanical ventilation (MV) management is an essential skill for pulmonary and critical care medicine (PCCM) fellows to master during training. The unprecedented emergence of the coronavirus disease (COVID-19) pandemic highlighted the need for advanced operator competency in MV to improve patients’ outcomes. Objective We aimed to create a standardized case-based curriculum using a blended approach of high-fidelity simulation, rapid-cycle deliberate practice, video didactics, and hands-on small group sessions for rapid accumulation of knowledge and hands-on skills for PCCM fellows before caring for critically ill patients during the COVID-19 pandemic. Methods The MV curriculum consisted of the following steps: 1) baseline written knowledge test with 15 multiple-choice questions covering MV, the latest evidence-based practices, and pathophysiology of COVID-19; 2) baseline confidence survey using a 5-point Likert scale; 3) a one-on-one session using a high-fidelity simulation manikin, a lung simulator, and a mechanical ventilator to test baseline competencies; 4) a structured debriefing tailored per fellow’s 50-point competency assessment checklist from the simulation using rapid-cycle deliberate practice; 5) video didactics; 6) a hands-on session in small groups for basic knobology, waveforms, and modes of MV; 7) a one-on-one simulation reassessment session; 8) a written knowledge posttest; and 9) a post-training confidence survey using a 5-point Likert scale. Results Eight PCCM fellows completed the training. The mean multiple-choice question score increased from 7.4 ± 2.9 to 10.4 ± 2.4 (P &lt; 0.05), and the simulation scores increased from 17.1 ± 4.4 to 30.8 ± 3.7 (P &lt; 0.05). Comparing the simulation reassessment to the baseline, fellows showed significant improvement (P &lt; 0.05) in assessing indications for MV; implementing rapid sequence intubation for patients with COVID-19; initiating MV and ventilator bundle per best practices; recognizing and managing mucous plugging, ventilator dyssynchrony, and evidence-based treatments for acute respiratory distress syndrome; and developing a care plan for proning. The post-training survey revealed improved learner confidence in all competencies. Conclusion This pilot MV curriculum using a blended approach was feasible and allowed PCCM fellows to significantly improve their knowledge and hands-on skills, allowing for the appropriate use of MV during the pandemic. Self-reported improvement scores further reinforced this. The emergent need for novice learners may again be necessary for future pandemic settings where standard training models requiring extensive training time are limited.
Toward the Deimplementation of Computed Tomography Urogram for Patients With Low- to Intermediate-risk Microscopic Hematuria: A Mixed-method Study of Factors Influencing Continued Use
Birken, Sarah A. , Matulewicz, Richard S. , Pathak, Ram A. , Wagi, Cheyenne R. , Peluso, Alexandra G., Bundy, Richa , Witek, Lauren , Krol, Bridget , Dharod, Ajay , Parchman, Michael Leo , Nielsen, Matthew E.

Mayo Clinic

Urology Practice | July 27, 2023 | Volume: 10 | Issue: 5 | Pages: 511-519

10.1097/upj.0000000000000429 | PMID 37499130 Get It

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303
Russler‐Germain, David A. , Krysiak, Kilannin , Ramirez, Cody A. , Watkins, Marcus P. , Gomez, Felicia , Trani, Lee , Geyer, Susan M. , Cashen, Amanda F. , Mehta–Shah, Neha , Alderuccio, Juan Pablo , Lossos, Izidore S. , Ondrejka, Sarah L. , Leonard, John P. , Griffith, Malachi , Griffith, Obi L. , Fehniger, Todd A. , Ramirez, Cody , Watkins, Marcus , Gomez, Felicia , Mehta-Shah, Neha , Kahl, Brad S , Bartlett, Nancy L , Alderuccio, Juan Pablo , Lossos, Izidore S , Ondrejka, Sarah , Hsi, Eric D , Griffith, Obi L , Fehniger, Todd A , Krysiak, Kilannin , Griffith, Malachi , Russler-Germain, David A , Mosior, Matthew , Skidmore, Zachary L. , Gao, Feng , Kahl, Brad S. , Bartlett, Nancy L. , Hsi, Eric D. , Martin, Peter

Mayo Clinic

Blood Advances | July 26, 2023 | Volume: 7 | Issue: 18 | Pages: 5524-5539

10.1182/bloodadvances.2023010779 | PMID 37493986 Get It

Abstract Follicular lymphoma (FL) is clinically heterogeneous, with select patients tolerating extended watch-and-wait, whereas others require prompt treatment, suffer progression of disease within 24 months of treatment (POD24), and/or experience aggressive histologic transformation (t-FL). Because our understanding of the relationship between genetic alterations in FL and patient outcomes remains limited, we conducted a clinicogenomic analysis of 370 patients with FL or t-FL (from Cancer and Leukemia Group B/Alliance trials 50402/50701/50803, or real-world cohorts from Washington University School of Medicine, Cleveland Clinic, or University of Miami). FL subsets by grade, stage, watch-and-wait, or POD24 status did not differ by mutation burden, whereas mutation burden was significantly higher in relapsed/refractory (rel/ref) FL and t-FL than in newly diagnosed (dx) FL. Nonetheless, mutation burden in dx FL was not associated with frontline progression-free survival (PFS). CREBBP was the only gene more commonly mutated in FL than in t-FL yet mutated CREBBP was associated with shorter frontline PFS in FL. Mutations in 20 genes were more common in rel/ref FL or t-FL than in dx FL, including 6 significantly mutated genes (SMGs): STAT6, TP53, IGLL5, B2M, SOCS1, and MYD88. We defined a mutations associated with progression (MAP) signature as ≥2 mutations in these 7 genes (6 rel/ref FL or t-FL SMGs plus CREBBP). Patients with dx FL possessing a MAP signature had shorter frontline PFS, revealing a 7-gene set offering insight into FL progression risk potentially more generalizable than the m7–Follicular Lymphoma International Prognostic Index (m7-FLIPI), which had modest prognostic value in our cohort. Future studies are warranted to validate the poor prognosis associated with a MAP signature in dx FL, potentially facilitating novel trials specifically in this high-risk subset of patients.